UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012018 |
|---|---|
| Receipt number | R000014023 |
| Scientific Title | Combination therapy of Eribulin, Trastuzumab and Pertuzumab for the treatment of patients with previously treated advanced HER2-positive breast cancer. |
| Date of disclosure of the study information | 2013/10/10 |
| Last modified on | 2018/03/19 14:53:24 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/10/10 23:14:25 | ||
| 2 | Update | 2015/10/13 15:31:01 | Recruitment status |
|
| 3 | Update | 2017/09/27 09:11:11 | Recruitment status |
|
| 4 | Update | 2018/03/19 14:53:24 | Publication of results |
